Skip to main content
. 2017 Jun 24;12(1):105–109. doi: 10.1007/s12105-017-0835-9

Table 1.

Metastatic characteristics of evaluated thyroid tumors

NIFTP FVPTC Mixed histology p value
Number of cases (total) 47 (37%) 28 (22%) 45 (35%)
Mean and range time of patient follow-up (in days) 611.17 714.63 707.71 0.74
(0–2310.0) (0–2275.0) (0–2104.0)
Average tumor size in cm (largest focus) 1.72 1.43 2.10 0.20
Average number of foci 1.42 1.71 1.98 0.01
Number of cases with nodal evaluation 13/47 (27.7%) 17/28 (60.7%) 29/45 (64.4%) <0.01
Average number of LNs examined 7.58 11.31 25.4 <0.01
Number of cases with positive lymph nodes 0/47 (0%) 7/28 (25.0%) 17/45 (37.7%) 0.43
Location of positive lymph nodesa,b pN1a = 0 cases pN1a = 3 cases (10.7%) pN1a = 5 cases (11.1%) <0.01
pN1b = 0 cases pN1b = 4 cases (14.2%) pN1b = 12 cases (26.6%)
Number of positive nodal cases with extra-thyroidal extension 0/0 (0%) 1/7 (14.2%) 12/17 (70.6%) 0.02

a pN1a metastasis to level VI (pretracheal, paratracheal and prelaryngeal/Delphian, perithyroidal) lymph nodes

b pN1b metastasis to unilateral, bilateral or contralateral cervical (levels I, II, III, IV, V) or retropharyngeal or superior mediastinal lymph nodes (level VII)